Chronic Radiation Dermatitis Secondary to Narrow-Band Ultraviolet B Therapy in a Patient With Primary Cutaneous CD8+ T-Cell Lymphoma With Cytotoxic Granules-Reference-Cited by-同舟云学术

Chronic Radiation Dermatitis Secondary to Narrow-Band Ultraviolet B Therapy in a Patient With Primary Cutaneous CD8+ T-Cell Lymphoma With Cytotoxic Granules

Published:2024-03-12 Issue: Volume: Page:
ISSN:0193-1091
Container-title:The American Journal of Dermatopathology
language:en
Short-container-title:

Author:

Edelson Mia P.¹,Gay Jane J.²,Thiel Robert W.²,Grider Douglas J.²³⁴^ORCID

Affiliation:

1. Virginia Tech Carilion School of Medicine, Roanoke, VA;

2. Division of Dermatology, Department of Internal Medicine, Virginia Tech Carilion School of Medicine, Roanoke, VA;

3. Dominion Pathology Associates, Roanoke, VA; and

4. Department of Basic Science Education, Virginia Tech Carilion School of Medicine, Roanoke, VA.

Abstract

Abstract: Conventional therapies for CD8+ cutaneous T-cell lymphoma include topical steroids, topical nitrogen mustard, topical bexarotene, ultraviolet B therapy, psoralen and ultraviolet A therapy, local radiotherapy, and interferon alfa; however, these treatments are often found to be ineffective. Presented is a case of CD8+ cutaneous T-cell lymphoma with near-complete response to narrow-band ultraviolet therapy because of chronic radiation dermatitis initially believed to be possible progression of a CD8+ cutaneous epidermotropic cytotoxic T-cell lymphoma.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference17 articles.

1. Primary cutaneous lymphoma: an overview based on the WHO-EORTC classification;Asher;Diagn Histopathology,2010

2. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior;Berti;Am J Pathol,1999

3. CD8-positive mycosis fungoides and primary cutaneous aggressive epidermotropic CD8-positive cytotoxic T-cell lymphoma;Diwan;J Cutan Pathol,2009

4. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma;Gormley;J Am Acad Dermatol,2010

5. Management of advanced-stage peripheral T-cell lymphomas;Kimby;Curr Hematol Malig Rep,2007